Suraksha Diagnostic Ltd Q2 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Suraksha Diagnostic Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Suraksha Diagnostic Ltd management said on order book — free account, 30 seconds.
Capex plans
Track Suraksha Diagnostic Ltd — get its next earnings analysis in your feed
Margin guidance
Order book
How does Suraksha Diagnostic Ltd rank vs peers in Healthcare Services?
Pro featureHow does Suraksha Diagnostic Ltd rank in Healthcare Services?
Compare Suraksha Diagnostic Ltd against every Healthcare Services company (Q2 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Suraksha Diagnostic Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Metropolis Healt (Q1 FY27)
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
- Apollo Hospitals (Q1 FY27)
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
- Health X Platform Ltd (Q1 FY27)
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…
- Shalby Ltd (Q1 FY27)
Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…